Shrinkage of Olfactory Amygdala Connotes Cognitive Impairment in Patients with Parkinson's Disease

Overview

Journal Cogn Neurodyn

Publisher Springer

Specialty Neurology

Date 2023 Oct 3

PMID 37786655

Authors

Ulas Ay

Zerrin Yildirim

Emel Erdogdu

Ani Kicik

Esin Ozturk-Isik

Tamer Demiralp

Hakan Gurvit

Affiliations

Soon will be listed here.

Abstract

Supplementary Information: The online version contains supplementary material available at 10.1007/s11571-022-09887-y.

Citing Articles

Automated brain segmentation and volumetry in dementia diagnostics: a narrative review with emphasis on FreeSurfer.

Khadhraoui E, Nickl-Jockschat T, Henkes H, Behme D, Muller S Front Aging Neurosci. 2024; 16:1459652.

PMID: 39291276 PMC: 11405240. DOI: 10.3389/fnagi.2024.1459652.

Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks.

Jellinger K Int J Mol Sci. 2024; 25(1).

PMID: 38203667 PMC: 10778722. DOI: 10.3390/ijms25010498.

Fine-grained features characterize hippocampal and amygdaloid change pattern in Parkinson's disease and discriminate cognitive-deficit subtype.

Zhang L, Zhang P, Dong Q, Zhao Z, Zheng W, Zhang J CNS Neurosci Ther. 2023; 30(1):e14480.

PMID: 37849445 PMC: 10805398. DOI: 10.1111/cns.14480.

References

Williams-Gray C, Foltynie T, Brayne C, Robbins T, Barker R . Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain. 2007; 130(Pt 7):1787-98. DOI: 10.1093/brain/awm111. View

Aarsland D, Kurz M . The epidemiology of dementia associated with Parkinson's disease. Brain Pathol. 2010; 20(3):633-9. PMC: 8094858. DOI: 10.1111/j.1750-3639.2009.00369.x. View

Litvan I, Aarsland D, Adler C, Goldman J, Kulisevsky J, Mollenhauer B . MDS Task Force on mild cognitive impairment in Parkinson's disease: critical review of PD-MCI. Mov Disord. 2011; 26(10):1814-24. PMC: 3181006. DOI: 10.1002/mds.23823. View

Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K . Stages in the development of Parkinson's disease-related pathology. Cell Tissue Res. 2004; 318(1):121-34. DOI: 10.1007/s00441-004-0956-9. View

Adler C, Beach T, Zhang N, Shill H, Driver-Dunckley E, Caviness J . Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging. J Neuropathol Exp Neurol. 2019; 78(10):891-899. PMC: 6751070. DOI: 10.1093/jnen/nlz080. View

Beyer M, Janvin C, Larsen J, Aarsland D . A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry. 2006; 78(3):254-9. PMC: 2117633. DOI: 10.1136/jnnp.2006.093849. View

Kadohisa M . Effects of odor on emotion, with implications. Front Syst Neurosci. 2013; 7:66. PMC: 3794443. DOI: 10.3389/fnsys.2013.00066. View

Azamat S, Arslan D, Erdogdu E, Kicik A, Cengiz S, Eryurek K . Detection of visual and frontoparietal network perfusion deficits in Parkinson's disease dementia. Eur J Radiol. 2021; 144:109985. DOI: 10.1016/j.ejrad.2021.109985. View

Del Tredici K, Rub U, de Vos R, Bohl J, Braak H . Where does parkinson disease pathology begin in the brain?. J Neuropathol Exp Neurol. 2002; 61(5):413-26. DOI: 10.1093/jnen/61.5.413. View

10.

Aarsland D, Bronnick K, Larsen J, Tysnes O, Alves G . Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology. 2008; 72(13):1121-6. DOI: 10.1212/01.wnl.0000338632.00552.cb. View

11.

Emre M, Aarsland D, Brown R, Burn D, Duyckaerts C, Mizuno Y . Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007; 22(12):1689-707. DOI: 10.1002/mds.21507. View

12.

Santangelo G, Vitale C, Picillo M, Moccia M, Cuoco S, Longo K . Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study. Parkinsonism Relat Disord. 2015; 21(10):1219-26. DOI: 10.1016/j.parkreldis.2015.08.024. View

13.

Pigott K, Rick J, Xie S, Hurtig H, Chen-Plotkin A, Duda J . Longitudinal study of normal cognition in Parkinson disease. Neurology. 2015; 85(15):1276-82. PMC: 4617168. DOI: 10.1212/WNL.0000000000002001. View

14.

Pessoa L . Emotion and cognition and the amygdala: from "what is it?" to "what's to be done?". Neuropsychologia. 2010; 48(12):3416-29. PMC: 2949460. DOI: 10.1016/j.neuropsychologia.2010.06.038. View

15.

Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U . Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages). J Neurol. 2003; 249 Suppl 3:III/1-5. DOI: 10.1007/s00415-002-1301-4. View

16.

Baba T, Kikuchi A, Hirayama K, Nishio Y, Hosokai Y, Kanno S . Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: a 3 year longitudinal study. Brain. 2012; 135(Pt 1):161-9. DOI: 10.1093/brain/awr321. View

17.

Buter T, van den Hout A, Matthews F, Larsen J, Brayne C, Aarsland D . Dementia and survival in Parkinson disease: a 12-year population study. Neurology. 2008; 70(13):1017-22. DOI: 10.1212/01.wnl.0000306632.43729.24. View

18.

Kalaitzakis M, Graeber M, Gentleman S, Pearce R . Controversies over the staging of alpha-synuclein pathology in Parkinson's disease. Acta Neuropathol. 2008; 116(1):125-8. DOI: 10.1007/s00401-008-0381-3. View

19.

Kempster P, OSullivan S, Holton J, Revesz T, Lees A . Relationships between age and late progression of Parkinson's disease: a clinico-pathological study. Brain. 2010; 133(Pt 6):1755-62. DOI: 10.1093/brain/awq059. View

20.

Arslan D, Gurvit H, Genc O, Kicik A, Eryurek K, Cengiz S . The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI. J Neural Transm (Vienna). 2020; 127(9):1285-1294. DOI: 10.1007/s00702-020-02227-6. View